Verici Dx Future Growth
Future criteria checks 2/6
Verici Dx is forecast to grow revenue at 78.8% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 42.4% |
| Revenue growth rate | 78.8% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 11 Oct 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 12 | N/A | -1 | N/A | 1 |
| 12/31/2024 | 4 | N/A | -8 | N/A | 1 |
| 6/30/2024 | 4 | -5 | -6 | -6 | N/A |
| 3/31/2024 | 3 | -7 | -7 | -6 | N/A |
| 12/31/2023 | 1 | -9 | -7 | -7 | N/A |
| 9/30/2023 | 1 | -10 | -9 | -8 | N/A |
| 6/30/2023 | 0 | -11 | -10 | -10 | N/A |
| 3/31/2023 | 0 | -11 | -11 | -10 | N/A |
| 12/31/2022 | N/A | -11 | -11 | -10 | N/A |
| 9/30/2022 | N/A | -11 | -10 | -9 | N/A |
| 6/30/2022 | N/A | -11 | -10 | -9 | N/A |
| 3/31/2022 | N/A | -10 | -8 | -7 | N/A |
| 12/31/2021 | N/A | -8 | -7 | -6 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 63V's forecast earnings growth is above the savings rate (1%).
Earnings vs Market: Insufficient data to determine if 63V's earnings are forecast to grow faster than the German market
High Growth Earnings: Insufficient data to determine if 63V's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 63V's revenue (78.8% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 63V's revenue (78.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 63V's Return on Equity is forecast to be high in 3 years time